Logo image of SVS.MI

SVAS BIOSANA SPA (SVS.MI) Stock Fundamental Analysis

BIT:SVS - Euronext Milan - IT0005469264 - Common Stock - Currency: EUR

7.94  -0.24 (-2.93%)

Fundamental Rating

6

Taking everything into account, SVS scores 6 out of 10 in our fundamental rating. SVS was compared to 58 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of SVS get a neutral evaluation. Nothing too spectacular is happening here. SVS is growing strongly while it also seems undervalued. This is an interesting combination


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year SVS was profitable.
In the past year SVS had a positive cash flow from operations.
Each year in the past 5 years SVS has been profitable.
SVS had a positive operating cash flow in each of the past 5 years.
SVS.MI Yearly Net Income VS EBIT VS OCF VS FCFSVS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 2M -2M 4M 6M 8M

1.2 Ratios

With a Return On Assets value of 3.44%, SVS perfoms like the industry average, outperforming 53.33% of the companies in the same industry.
SVS has a Return On Equity of 9.25%. This is in the better half of the industry: SVS outperforms 70.00% of its industry peers.
With a decent Return On Invested Capital value of 7.57%, SVS is doing good in the industry, outperforming 73.33% of the companies in the same industry.
SVS had an Average Return On Invested Capital over the past 3 years of 6.10%. This is in line with the industry average of 8.02%.
The 3 year average ROIC (6.10%) for SVS is below the current ROIC(7.57%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.44%
ROE 9.25%
ROIC 7.57%
ROA(3y)2.62%
ROA(5y)2.53%
ROE(3y)7.15%
ROE(5y)8.28%
ROIC(3y)6.1%
ROIC(5y)6.5%
SVS.MI Yearly ROA, ROE, ROICSVS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2 4 6 8 10

1.3 Margins

SVS's Profit Margin of 4.49% is in line compared to the rest of the industry. SVS outperforms 53.33% of its industry peers.
In the last couple of years the Profit Margin of SVS has grown nicely.
SVS has a Operating Margin of 8.07%. This is comparable to the rest of the industry: SVS outperforms 51.67% of its industry peers.
SVS's Operating Margin has improved in the last couple of years.
SVS has a Gross Margin of 25.79%. This is amonst the worse of the industry: SVS underperforms 83.33% of its industry peers.
In the last couple of years the Gross Margin of SVS has declined.
Industry RankSector Rank
OM 8.07%
PM (TTM) 4.49%
GM 25.79%
OM growth 3Y4.61%
OM growth 5Y3.21%
PM growth 3Y9.42%
PM growth 5Y9.36%
GM growth 3Y-7.01%
GM growth 5Y-4.71%
SVS.MI Yearly Profit, Operating, Gross MarginsSVS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 10 20 30

4

2. Health

2.1 Basic Checks

SVS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, SVS has less shares outstanding
The number of shares outstanding for SVS has been reduced compared to 5 years ago.
Compared to 1 year ago, SVS has a worse debt to assets ratio.
SVS.MI Yearly Shares OutstandingSVS.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
SVS.MI Yearly Total Debt VS Total AssetsSVS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

SVS has an Altman-Z score of 1.86. This is not the best score and indicates that SVS is in the grey zone with still only limited risk for bankruptcy at the moment.
SVS has a Altman-Z score (1.86) which is comparable to the rest of the industry.
SVS has a debt to FCF ratio of 1707.47. This is a negative value and a sign of low solvency as SVS would need 1707.47 years to pay back of all of its debts.
With a Debt to FCF ratio value of 1707.47, SVS perfoms like the industry average, outperforming 46.67% of the companies in the same industry.
A Debt/Equity ratio of 0.64 indicates that SVS is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.64, SVS is doing worse than 70.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 1707.47
Altman-Z 1.86
ROIC/WACC1.1
WACC6.89%
SVS.MI Yearly LT Debt VS Equity VS FCFSVS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 20M 40M

2.3 Liquidity

A Current Ratio of 1.96 indicates that SVS should not have too much problems paying its short term obligations.
SVS has a Current ratio (1.96) which is comparable to the rest of the industry.
A Quick Ratio of 1.42 indicates that SVS should not have too much problems paying its short term obligations.
SVS's Quick ratio of 1.42 is fine compared to the rest of the industry. SVS outperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.42
SVS.MI Yearly Current Assets VS Current LiabilitesSVS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

7

3. Growth

3.1 Past

SVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.52%, which is quite impressive.
SVS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.81% yearly.
SVS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.19%.
SVS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.34% yearly.
EPS 1Y (TTM)32.52%
EPS 3Y28.6%
EPS 5Y22.81%
EPS Q2Q%15.52%
Revenue 1Y (TTM)12.19%
Revenue growth 3Y15.87%
Revenue growth 5Y11.34%
Sales Q2Q%5.91%

3.2 Future

Based on estimates for the next years, SVS will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.90% on average per year.
Based on estimates for the next years, SVS will show a quite strong growth in Revenue. The Revenue will grow by 8.45% on average per year.
EPS Next Y20.69%
EPS Next 2Y22.24%
EPS Next 3Y16.9%
EPS Next 5YN/A
Revenue Next Year5.8%
Revenue Next 2Y10.19%
Revenue Next 3Y8.45%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SVS.MI Yearly Revenue VS EstimatesSVS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M
SVS.MI Yearly EPS VS EstimatesSVS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0.5 1

8

4. Valuation

4.1 Price/Earnings Ratio

SVS is valuated cheaply with a Price/Earnings ratio of 7.78.
98.33% of the companies in the same industry are more expensive than SVS, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.45. SVS is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 6.05, the valuation of SVS can be described as very cheap.
SVS's Price/Forward Earnings ratio is rather cheap when compared to the industry. SVS is cheaper than 96.67% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.90. SVS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.78
Fwd PE 6.05
SVS.MI Price Earnings VS Forward Price EarningsSVS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SVS is valued cheaply inside the industry as 90.00% of the companies are valued more expensively.
SVS's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 1195.27
EV/EBITDA 3.54
SVS.MI Per share dataSVS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SVS has a very decent profitability rating, which may justify a higher PE ratio.
SVS's earnings are expected to grow with 16.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.38
PEG (5Y)0.34
EPS Next 2Y22.24%
EPS Next 3Y16.9%

4

5. Dividend

5.1 Amount

SVS has a Yearly Dividend Yield of 3.16%.
SVS's Dividend Yield is rather good when compared to the industry average which is at 2.07. SVS pays more dividend than 90.00% of the companies in the same industry.
SVS's Dividend Yield is a higher than the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 3.16%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y22.24%
EPS Next 3Y16.9%
SVS.MI Yearly Income VS Free CF VS DividendSVS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 0 2M -2M 4M

SVAS BIOSANA SPA

BIT:SVS (6/19/2025, 7:00:00 PM)

7.94

-0.24 (-2.93%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners6.77%
Inst Owner ChangeN/A
Ins Owners64.79%
Ins Owner ChangeN/A
Market Cap44.46M
Analysts80
Price Target13.87 (74.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.16%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.68%
PT rev (3m)9.68%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.87%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE 7.78
Fwd PE 6.05
P/S 0.37
P/FCF 1195.27
P/OCF 7.26
P/B 0.75
P/tB 0.94
EV/EBITDA 3.54
EPS(TTM)1.02
EY12.85%
EPS(NY)1.31
Fwd EY16.54%
FCF(TTM)0.01
FCFY0.08%
OCF(TTM)1.09
OCFY13.77%
SpS21.7
BVpS10.52
TBVpS8.44
PEG (NY)0.38
PEG (5Y)0.34
Profitability
Industry RankSector Rank
ROA 3.44%
ROE 9.25%
ROCE 9.95%
ROIC 7.57%
ROICexc 11.41%
ROICexgc 13.88%
OM 8.07%
PM (TTM) 4.49%
GM 25.79%
FCFM 0.03%
ROA(3y)2.62%
ROA(5y)2.53%
ROE(3y)7.15%
ROE(5y)8.28%
ROIC(3y)6.1%
ROIC(5y)6.5%
ROICexc(3y)9.61%
ROICexc(5y)8.9%
ROICexgc(3y)11.85%
ROICexgc(5y)10.85%
ROCE(3y)8.02%
ROCE(5y)10.69%
ROICexcg growth 3Y15.29%
ROICexcg growth 5Y7.17%
ROICexc growth 3Y14.84%
ROICexc growth 5Y6.65%
OM growth 3Y4.61%
OM growth 5Y3.21%
PM growth 3Y9.42%
PM growth 5Y9.36%
GM growth 3Y-7.01%
GM growth 5Y-4.71%
F-Score8
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 1707.47
Debt/EBITDA 2.51
Cap/Depr 118.33%
Cap/Sales 5.01%
Interest Coverage 250
Cash Conversion 40.95%
Profit Quality 0.68%
Current Ratio 1.96
Quick Ratio 1.42
Altman-Z 1.86
F-Score8
WACC6.89%
ROIC/WACC1.1
Cap/Depr(3y)116.12%
Cap/Depr(5y)115.75%
Cap/Sales(3y)5.74%
Cap/Sales(5y)5.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.52%
EPS 3Y28.6%
EPS 5Y22.81%
EPS Q2Q%15.52%
EPS Next Y20.69%
EPS Next 2Y22.24%
EPS Next 3Y16.9%
EPS Next 5YN/A
Revenue 1Y (TTM)12.19%
Revenue growth 3Y15.87%
Revenue growth 5Y11.34%
Sales Q2Q%5.91%
Revenue Next Year5.8%
Revenue Next 2Y10.19%
Revenue Next 3Y8.45%
Revenue Next 5YN/A
EBIT growth 1Y24.73%
EBIT growth 3Y21.21%
EBIT growth 5Y14.92%
EBIT Next Year83.74%
EBIT Next 3Y31.21%
EBIT Next 5Y24.44%
FCF growth 1Y100.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y212.56%
OCF growth 3Y9.06%
OCF growth 5Y6.2%